Ramon M. Marrades

Madrid, MD 28029, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Clinical Application of Expert Software Based on Six Tumour Biomarkers to Stratify the Risk of Lung Cancer in a Pulmonary Rapid Diagnosis Unit.

Clinical Application of Expert Software Based on Six Tumour Biomarkers to Stratify the Risk of Lung Cancer in a Pulmonary Rapid Diagnosis Unit.

Journal: Archivos de bronconeumologia

Published: August 19, 2025

Diagnostic and Prognostic Value of hsa_piR_022710, hsa_piR_019822, and hsa_piR_020840 in Early-Stage Non-Small-Cell Lung Cancer: Implications for Recurrence and Survival in Squamous Cell Carcinoma Patients.

Diagnostic and Prognostic Value of hsa_piR_022710, hsa_piR_019822, and hsa_piR_020840 in Early-Stage Non-Small-Cell Lung Cancer: Implications for Recurrence and Survival in Squamous Cell Carcinoma Patients.

Journal: International journal of molecular sciences

Published: February 20, 2025

Discovering genes and microRNAs involved in human lung development unveils IGFBP3/miR-34a dynamics and their relevance for alveolar differentiation.

Discovering genes and microRNAs involved in human lung development unveils IGFBP3/miR-34a dynamics and their relevance for alveolar differentiation.

Journal: Stem cell research & therapy

Published: July 04, 2024

Selection of the Most Suitable Culture Medium for Patient-Derived Lung Cancer Organoids.

Selection of the Most Suitable Culture Medium for Patient-Derived Lung Cancer Organoids.

Journal: Cells, tissues, organs

Published: April 04, 2024

EBUS-TBNA in Extrathoracic Malignancies: Diagnostic and Prognostic Implications.

EBUS-TBNA in Extrathoracic Malignancies: Diagnostic and Prognostic Implications.

Journal: Lung

Published: August 12, 2022

Integral mediastinal staging in patients with NON-SMALL cell lung cancer and risk factors for occult N2 disease.

Integral mediastinal staging in patients with NON-SMALL cell lung cancer and risk factors for occult N2 disease.

Journal: Respiratory medicine

Published: August 02, 2022

Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer.

Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer.

Journal: Translational lung cancer research

Published: May 20, 2021

Monitoring HOTTIP levels on extracellular vesicles for predicting recurrence in surgical non-small cell lung cancer patients.

Monitoring HOTTIP levels on extracellular vesicles for predicting recurrence in surgical non-small cell lung cancer patients.

Journal: Translational oncology

Published: April 28, 2021

Tumour markers with clinically controlled cut-offs for suspected cancer.

Tumour markers with clinically controlled cut-offs for suspected cancer.

Journal: European journal of clinical investigation

Published: January 11, 2021

A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test.

A continuous responder algorithm to optimize clinical management of small-cell lung cancer with progastrin-releasing peptide as a simple blood test.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 23, 2020

Is invasive mediastinal staging necessary in intermediate risk patients with negative PET/CT?

Is invasive mediastinal staging necessary in intermediate risk patients with negative PET/CT?

Journal: Journal of thoracic disease

Published: September 18, 2020

Extracellular Vesicle lincRNA-p21 Expression in Tumor-Draining Pulmonary Vein Defines Prognosis in NSCLC and Modulates Endothelial Cell Behavior.

Extracellular Vesicle lincRNA-p21 Expression in Tumor-Draining Pulmonary Vein Defines Prognosis in NSCLC and Modulates Endothelial Cell Behavior.

Journal: Cancers

Published: February 26, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026